Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks.
Dupont AC, Arlicot N, Vercouillie J, Serrière S, Maia S, Bonnet-Brilhault F, Santiago-Ribeiro MJ. Dupont AC, et al. Among authors: vercouillie j. Pharmaceuticals (Basel). 2023 Aug 10;16(8):1127. doi: 10.3390/ph16081127. Pharmaceuticals (Basel). 2023. PMID: 37631042 Free PMC article. Review.
Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers.
Dupont AC, Serrière S, Barantin L, Vercouillie J, Tauber C, Gissot V, Bodard S, Chicheri G, Chalon S, Bonnet-Brilhault PF, Santiago-Ribeiro PM, Arlicot N. Dupont AC, et al. Among authors: vercouillie j. Transl Psychiatry. 2021 Jan 20;11(1):66. doi: 10.1038/s41398-020-01152-2. Transl Psychiatry. 2021. PMID: 33473111 Free PMC article.
Glutamatergic synapse in autism: a complex story for a complex disorder.
Galineau L, Arlicot N, Dupont AC, Briend F, Houy-Durand E, Tauber C, Gomot M, Gissot V, Barantin L, Lefevre A, Vercouillie J, Roussel C, Roux S, Nadal L, Mavel S, Laumonnier F, Belzung C, Chalon S, Emond P, Santiago-Ribeiro MJ, Bonnet-Brilhault F. Galineau L, et al. Among authors: vercouillie j. Mol Psychiatry. 2023 Feb;28(2):801-809. doi: 10.1038/s41380-022-01860-9. Epub 2022 Nov 25. Mol Psychiatry. 2023. PMID: 36434055
Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain.
Vala C, Mothes C, Chicheri G, Magadur P, Viot G, Deloye JB, Maia S, Bouvet Y, Dupont AC, Arlicot N, Guilloteau D, Emond P, Vercouillie J. Vala C, et al. Among authors: vercouillie j. EJNMMI Radiopharm Chem. 2020 Nov 16;5(1):26. doi: 10.1186/s41181-020-00105-w. EJNMMI Radiopharm Chem. 2020. PMID: 33196944 Free PMC article.
[18 F]-labeled positron emission tomography ligand for the histamine H4 receptor.
Zak A, Lemaire L, Chalon S, Chicheri G, Marzag H, Bodard S, Sérrière S, Routier S, Buron F, Vercouillie J. Zak A, et al. Among authors: vercouillie j. J Labelled Comp Radiopharm. 2021 Jul;64(9):363-372. doi: 10.1002/jlcr.3929. Epub 2021 Jun 15. J Labelled Comp Radiopharm. 2021. PMID: 34089268
Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches.
Vetel S, Sérrière S, Vercouillie J, Vergote J, Chicheri G, Deloye JB, Dollé F, Bodard S, Tronel C, Nadal-Desbarats L, Lefèvre A, Emond P, Chalon S. Vetel S, et al. Among authors: vercouillie j. Synapse. 2019 Mar;73(3):e22077. doi: 10.1002/syn.22077. Epub 2018 Nov 12. Synapse. 2019. PMID: 30368914 Free article.
The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use.
Chalon S, Vercouillie J, Payoux P, Deloye JB, Malherbe C, Le Jeune F, Arlicot N, Salabert AS, Guilloteau D, Emond P, Ribeiro MJ. Chalon S, et al. Among authors: vercouillie j. Front Med (Lausanne). 2019 May 3;6:90. doi: 10.3389/fmed.2019.00090. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31131278 Free PMC article. Review.
50 results